mRNA turnover is an important regulatory component of gene expression and is significantly influenced by ribonucleoprotein (RNP) complexes which form on the mRNA. Studies of human ␣-globin mRNA stability have identified a specific RNP complex (␣-complex) which forms on the 3 untranslated region (3UTR) of the mRNA and appears to regulate the erythrocyte-specific accumulation of ␣-globin mRNA. One of the protein activities in this multiprotein complex is a poly(C)-binding activity which consists of two proteins, ␣CP1 and ␣CP2. Neither of these proteins, individually or as a pair, can bind the ␣-globin 3UTR unless they are complexed with the remaining non-poly(C) binding proteins of the ␣-complex. With the yeast two-hybrid screen, a second ␣-complex protein was identified. This protein is a member of the previously identified A؉U-rich (ARE) binding/degradation factor (AUF1) family of proteins, which are also known as the heterogeneous nuclear RNP (hnRNP) D proteins. We refer to these proteins as AUF1/hnRNP-D. Thus, a protein implicated in ARE-mediated mRNA decay is also an integral component of the mRNA stabilizing ␣-complex. The interaction of AUF1/hnRNP-D is more efficient with ␣CP1 relative to ␣CP2 both in vitro and in vivo, suggesting that the ␣-complex might be dynamic rather than a fixed complex. AUF1/hnRNP-D could, therefore, be a general mRNA turnover factor involved in both stabilization and decay of mRNA.
G cap and the poly(A) tail, contribute to the steady-state level of mRNA by promoting degradation or stabilization (38, 47) . Although these cis elements could occur anywhere on an mRNA, the overriding majority of these elements are localized to the 3Ј untranslated region (3ЈUTR), and, in conjunction with transacting factors, these elements either stabilize or destabilize the mRNA (13, 28, 44) . Several proto-oncogene and cytokine mRNAs contain similar yet distinct AϩU-rich elements (AREs) present in their 3ЈUTRs which promote degradation of the mRNA (13, 21) . The ARE generally consists of either scattered AUUUA pentanucleotides, contiguous AUUUA repeats, the nonamer motif UUAUUUAUU, or, in some cases, a stretch of adenylate and uridylate residues lacking either motif (9, 39, 68) . In the case of c-fos, the ARE appears to stimulate deadenylation and subsequent decay of the mRNA (51) . The precise mechanism by which this is accomplished remains unclear, although factors that bind to various AREs have been identified elsewhere (9) . The 3ЈUTR can also confer mRNA stability as demonstrated in the transferrin receptor mRNA. Two closely related iron response proteins (IRP-1 and IRP-2) bind the 3ЈUTR and protect the transferrin receptor mRNA from degradation (23) .
The globin mRNAs are among the most stable eukaryotic mRNAs, with estimated half-lives of as long as 60 h (42, 60) . This unusual stability is critical for the production and accumulation of hemoglobin in erythroid cells (2) . Due to the global transcriptional shutdown midway through erythroid cell development, it is the long-lived globin mRNAs that account for the selective accumulation of globin mRNAs and protein within a terminally differentiated reticulocyte. Recent studies have demonstrated that the stability of ␣-globin mRNA is regulated by a pyrimidine-rich cis element in the 3ЈUTR which, in conjunction with a specific ribonucleoprotein (RNP) complex (␣-complex), appears to mediate ␣-globin mRNA stability (62, 64, 65) . This complex is composed of multiple protein components which do not individually bind the ␣3ЈUTR directly but can do so within the context of the entire complex (37) . Therefore, protein-protein interactions between the various proteins in the complex are critical in forming a stable RNP complex on the ␣3ЈUTR. A prominent poly(C)-binding activity was identified within the complex, and this activity consists of two proteins, ␣-complex protein 1 and ␣-complex protein 2 (␣CP1 and ␣CP2, respectively; also known as PCBP-1 and -2 according to Leffers et al. [40] ). These two proteins are more than 80% identical, and each contains three KH-type RNA-binding domains (37, 40) . Although both proteins are avid poly(C)-binding proteins, they require the additional non-poly(C) binding components within the ␣-complex to bind the ␣3ЈUTR (37). We now report the identification of a second ␣CP family and demonstrate a differential interaction of these proteins with the two ␣CPs both in vitro and in vivo. These proteins have been described previously as the AREbinding/degradation factor AUF1 (16, 61, 66) and are also known as the heterogeneous nuclear RNP (hnRNP) D proteins (31), and they have been implicated in c-myc mRNA decay. Therefore, the ␣-complex is composed of proteins that can facilitate both mRNA stabilization and mRNA decay.
MATERIALS AND METHODS
Plasmid constructs. The plasmid pGBD-␣CP1, which expresses ␣CP1 fused to the GAL4 DNA-binding domain, was constructed by PCR amplification of ␣CP1 cDNA (from pGEM␣CP1-5.1 [37] ) with primers containing EcoRI restriction sites and inserted into the same site of the vector pGBT9 (Clontech). The plasmid expressing ␣CP2 fused to the GAL4 DNA-binding domain (pGBD-␣CP2) was similarly constructed with plasmid pVAC (40) to amplify the ␣CP2 coding region, except that an XhoI site was placed at the 3Ј end of the coding region. The PCR product was inserted into the EcoRI and SalI sites of the pGBT9 plasmid. Plasmid pGEX-␣CP1, which expresses glutathione S-transferase (GST)-␣CP1, contains the ␣CP1 coding region inserted into the modified pGEX2T plasmid pGEX2T-128/129 (Pharmacia) (17) . The coding region was amplified by PCR with appropriate primers and was inserted into the EcoRI site of the vector. The plasmid expressing the hnRNP U protein U-gly RNA-binding domain (amino acids 687 to 806) fused to the GAL4 DNA-binding domain was isolated as an EcoRI-PvuII fragment from pGem⌬5ЈMsc (35) which was inserted into the EcoRI and SmaI sites of pGBT9. All PCR constructs were confirmed by sequencing.
Extract preparation. Human erythroleukemia K562 cells were grown in RPMI 1640 supplemented with 10% fetal bovine serum containing 100 U of penicillin and 100 g of streptomycin per ml. Isolation of the S130 extract was carried out at 4°C as described by Brewer and Ross (5) with minor modifications. Cells were washed twice in phosphate-buffered saline (PBS) and resuspended in 1.5 ml of buffer A (10 mM Tris-HCl [pH 7.5], 1 mM potassium acetate, 1.5 mM magnesium acetate, 2 mM dithiothreitol) per 10 8 cells. The cells were lysed with 25 strokes of a type-B Dounce homogenizer, and nuclei were removed with a 10-min, 12,000 ϫ g centrifugation. The supernatant was layered over buffer A containing 30% (wt/vol) sucrose and centrifuged in an SW40 rotor at 130,000 ϫ g for 2.5 h. The supernatant was removed without disturbing the S130-sucrose interface and frozen in aliquots at Ϫ70°C.
Yeast two-hybrid interaction screening. The human HeLa cDNA library, plasmids pGBT9 and pGAD424, and S. cerevisiae Hf7c were obtained from Clontech, Inc. The library screening was carried out according to the manufacturer's suggested conditions, with approximately 6 ϫ 10 6 total transformants seeded. Clones which sustained growth in synthetic medium plates lacking leucine, tryptophan, and histidine were restreaked onto plates lacking leucine and tryptophan and tested for ␤-galactosidase activity with a nitrocellulose assay as described by the manufacturer. Of the original 67 positive growth colonies isolated, 19 contained ␤-galactosidase activity. The library plasmid from the HIS ϩ LacZ ϩ cells was recovered by transformation into Escherichia coli HB101 cells and retransformed into HF7c cells expressing pGBD-␣CP1 or pGBD-␣CP2 or expressing pGBD-Ugly as a negative control to confirm true positives. Of the 19 isolates, 9 were authentic interactions, 2 of which were the identical AUF1/hnRNP-D clone (the remainder will be detailed elsewhere).
In vitro production of proteins and protein-protein interactions. In vitro transcriptions-translations were carried out with the TNT rabbit reticulocyte system (Promega Biotech) as per the manufacturer's instructions with [ 35 S]methionine (Amersham). GST fusion proteins were produced in E. coli BL21 and purified on glutathione-Sepharose beads according to the manufacturer (Pharmacia). An aliquot of bacterial extract expressing GST-␣CP1, GST-␣CP2, or GST domain alone was incubated with 25 l of glutathione-Sepharose beads in PBS containing 0.5% Triton X-100 for 15 min at 4°C and washed four times in the same buffer followed by a PBS wash. Extract amounts were adjusted to yield approximately 4 g of glutathione-Sepharose-bound fusion protein per reaction. Protein-protein interaction reactions were carried out with an equivalent of 10 5 cpm of trichloroacetic acid-precipitable counts of 35 S-labeled, in vitro-translated protein incubated with GST fusion proteins coupled to glutathione-Sepharose beads for 1 h on a nutator at 4°C in binding buffer (PBS containing 2.5 mM MgCl 2 , 1.5 mM dithiothreitol, 3 g of leupeptin per ml, 0.5% aprotinin). The beads were subsequently washed five times in the same buffer plus 0.25% Triton X-100, resuspended in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer, and boiled for 3 min to elute proteins. The eluted proteins were resolved on an SDS-12.5% PAGE gel followed by autoradiography.
Isolation of ␣CPs. Large-scale electrophoretic mobility shift assays were carried out as described by Wang et al. (62) with minor modifications. Reactions were carried out in a total volume of 160 l with 500 ng of unlabeled ␣3ЈUTR RNA and 1.5 mg of K562 S130 extract. An aliquot of the ␣-complex formed on 32 P-labeled ␣3ЈUTR was also included to allow visualization of the complex. The sample used for the comigration control lane contained only S130 extract that was treated with micrococcal nuclease (400 U/ml) and RNase A (35 g/ml) at 30°C for 30 min to remove endogenous ␣-globin mRNA prior to use. The ␣-complex was excised from the native 6% polyacrylamide gel (with autoradiographic guidance), and the gel slice was soaked in 2ϫ SDS-PAGE sample buffer for 5 min prior to overlaying onto an SDS-12.5% PAGE gel. Resolved proteins were transferred onto nitrocellulose with a Hoefer Semi-Phor blotter at 150 mA for 1 h, and protein bands were visualized by Ponceau S staining (0.5% [wt/vol]) prior to Western analysis. AUF1/hnRNP-D proteins were detected with the 5B9 monoclonal antibody (kindly provided by Gideon Dreyfuss, University of Pennsylvania) with a 1:1,000 dilution of the primary antibody as described in Choi and Dreyfuss (10) and were visualized with an ECL Western detection kit (Amersham).
RESULTS

AUF1/hnRNP-D preferentially interacts with ␣CP1 in cells.
To gain a better understanding of the ␣-complex and the molecular mechanism by which it regulates mRNA stability, we initiated an identification of the protein components that constitute this complex using the yeast two-hybrid screen (18) . The human ␣CP1 coding region was fused to the GAL4 DNAbinding domain and used as the bait protein to screen a cDNA library. The human HeLa cDNA library was used, since the ␣-complex is present in HeLa cell extract (62) . One of the interacting proteins isolated was a partial cDNA encoding a protein identical to the previously identified ARE-binding/degradation factor (AUF1), which is a protein that binds the c-myc ARE and is believed to mediate decay of c-myc mRNA (4, 66) . The gene encoding this protein was recently shown to encode one of the hnRNP D proteins. The hnRNP D proteins are pre-mRNA binding proteins that also bind the single-stranded DNA region of telomeres in vitro (31, 45) . AUF1 (hnRNP D) is comprised of at least four isoforms derived by alternative splicing with apparent molecular masses of 37, 40, 42, and 45 kDa (4a, 31). These proteins are collectively referred to as AUF1/hnRNP-D. They each contain two RNP-CS-type RNAbinding domains and a glycine-rich carboxyl terminus (31, 66) and are thus members of the 2xRBD-Gly family of RNAbinding proteins (7, 36, 43) . The four protein products are identical, except for a 19-amino-acid insert near the amino terminus and a 49-amino-acid insert within the carboxyl-terminal glycine-rich region. Combinations which include or exclude the two stretches of amino acids give rise to the four isoforms (31) . The partial AUF1/hnRNP-D clone isolated by the two-hybrid screen is identical to the AUF1-p40 isoform protein, hnRNP D O B (31) , and begins at amino acid 90 and extends to the C terminus of the protein. Therefore, the predicted open reading frame of the identified clone interacting with ␣CP1 is consistent with AUF1-p40 and hnRNP D O B.
A summary of the two-hybrid interaction results is shown in Fig. 1 . An efficient interaction, as determined by the extent of LacZ activity, is detected between ␣CP1 and AUF1/hnRNP-D but not ␣CP1 alone (compare rows 1 and 4). The specificity of the interaction is demonstrated by replacement of ␣CP1 with a nonspecific RNA binding domain (the hnRNP U-glycine-rich RNA binding domain, U-gly [35] ) which does not result in an interaction (compare rows 1 to 3). The use of U-gly also controls for a false positive resulting from nonspecific RNA bridging between the two RNA binding proteins. Since both ␣CPs can be found within the ␣-complex, we also tested the ability of ␣CP2 to interact with AUF1/hnRNP-D. Surprisingly, the in-teraction of ␣CP2 with AUF1/hnRNP-D is significantly weaker than that of ␣CP1 with AUF1/hnRNP-D, even though the two ␣CPs are more than 80% identical (37) .
␣CP1 can preferentially interact with the AUF1/hnRNP-D isoforms in vitro. To begin addressing the macromolecular assembly and structure of the ␣-complex, we tested the in vitro interaction of ␣CP1 with the four different AUF1/hnRNP-D isoforms depicted schematically in Fig. 2A . The AUF1/ hnRNP-D proteins were translated in vitro with [ 35 S]methionine and incubated with bacterial extract expressing a GST fusion protein with ␣CP1 (GST-␣CP1). Following extensive washes, the interacting proteins were eluted and resolved on SDS-PAGE. As shown in Fig. 2B , all four AUF1/hnRNP-D isoforms have the capacity to interact with ␣CP1 in vitro but do not interact with the GST domain alone (lane 9). The prominent faster-migrating band in each translation is most likely an internal start site which truncates part of the amino terminus of the protein. Interestingly, these truncated proteins can also interact with ␣CP1. This is consistent with the fact that the clone isolated in the two-hybrid screen, which lacks the aminoterminal 90 amino acids, can interact with ␣CP1. The abilities of all four AUF1/hnRNP-D isoforms to interact with ␣CP2 were then tested. The results are consistent with the observation in vivo that the interaction with ␣CP2 was much less efficient than that with ␣CP1 (data not shown). A representative example of the comparative interaction of the AUF1-p42 isoform with ␣CP1 and ␣CP2 is shown in Fig. 3A (lanes 1 to 4) . The specificity of the interaction is demonstrated by the lack of detectable interactions between the hnRNP K protein and the ␣CPs (Fig. 3A, lanes 5 to 8) . The decrease in the interaction of GST-␣CP2 with AUF1/hnRNP-D is not due to a global denatured state of the fusion protein, since both GST-␣CP1 and GST-␣CP2 fusion proteins retain their abilities to bind nucleic acids (Fig. 3B) . This was demonstrated by testing the individual fusion protein's ability to bind 32 P-labeled poly(C) oligonucleotide (C 20 ). [ 32 P]C 20 oligonucleotide bound by the fusion protein was isolated with glutathione beads and resolved on a polyacrylamide-urea gel, followed by autoradiography. Therefore, the two ␣CPs vary in their capacities to interact with AUF1/hnRNP-D. While ␣CP1 can form a stable interaction with all four AUF1/hnRNP-D isoforms in vitro, the interaction of ␣CP2 with the AUF1/hnRNP-D isoforms is significantly reduced.
Studies of protein-protein interaction of RNA-binding proteins are complicated by the fact that both proteins can simultaneously bind the same RNA molecule and copurify due to RNA bridging rather than a direct interaction. Since both ␣CP1 and AUF1/hnRNP-D proteins are avid RNA-binding proteins, this concern was addressed by repeating the interaction assays in the presence of RNase. As shown in Fig. 4 , addition of RNase had no detectable effect on the interaction of AUF1/hnRNP-D with ␣CP1 or ␣CP2. The RNase-resistant property of the ␣CP-AUF1/hnRNP-D interaction is consistent with the ␣-complex, which is also an RNase-resistant complex (37, 62) .
AUF1/hnRNP-D is an ␣CP. The protein composition of the ␣-complex was examined to directly test whether the AUF1/ hnRNP-D proteins are part of the ␣-complex. The ␣-complex proteins were isolated as follows. K562 S130 extract was incubated with in vitro-transcribed (unlabeled) ␣3ЈUTR to form RNP complexes. The RNase-resistant ␣-complex was resolved on a native polyacrylamide gel and visualized by autoradiog- raphy (a small aliquot of 32 P-labeled ␣3ЈUTR was included as a tracer to visualize the ␣-complex [data not shown]). The area of the gel containing the ␣-complex was excised, and the gel slice was overlaid onto an SDS-PAGE gel. Similarly, an area comigrating with the ␣-complex in an adjacent lane containing only S130 extract and no ␣3ЈUTR was excised and used as a negative control. Thus, the proteins in the control lane were not ␣-complex specific. The proteins within the gel slices were resolved by SDS-PAGE, transferred to nitrocellulose, and visualized with Ponceau S protein staining. A comparison of lanes 2 and 3 in Fig. 5A demonstrates that there are several abundant proteins which appear to be ␣-complex specific. The six most abundant polypeptides have apparent molecular masses of 58, 55, 50, 45, 40, and 28 kDa, respectively. Although a 58-kDa band appears to be present in the control lane, closer examination reveals that this band does not comigrate with the band in the ␣-complex lane.
Immunodetection of the ␣CP blot with the hnRNP D-specific monoclonal antibody, 5B9 (26) , demonstrates the presence of the AUF1/hnRNP-D isoforms in the ␣-complex (Fig.  5B, compare lanes 2 and 3) . The AUF1-p40 and AUF1-p42 isoforms appear as the middle doublet band. The band detected in the negative control (lane 3) had a migration slightly slower than that of the AUF1-p40/AUF1-p42 band and appeared nonspecific. As a control, the blot was stripped and reprobed with the hnRNP C-specific antibody 4F4. As shown in Fig. 5C , the hnRNP C proteins are not present in the ␣-complex. Similarly, hnRNP K was also not detected in the ␣-complex (data not shown). Therefore, in addition to the ␣CPs (which comigrate with the 40-kDa band observed in the protein blot [data not shown]), the AUF1/hnRNP-D proteins are integral components of the ␣-complex.
DISCUSSION
The ␣-globin mRNA stability complex (␣-complex) consists of multiple protein components. We had initially identified the poly(C)-binding activity within the ␣-complex as two highly homologous proteins, which were termed ␣CP1 and ␣CP2 (37) . With the yeast two-hybrid screen (18) , an AUF1/ hnRNP-D protein isoform was identified as one that interacts specifically with ␣CP1 and was subsequently demonstrated to be a component of the ␣-complex. Identification of the AUF1/ hnRNP-D proteins as members of the ␣-complex indicates that these proteins might have a dual function in mRNA turnover. In addition to their potential role in the rapid decay of c-myc mRNA, their presence in the ␣-globin mRNA stability complex suggests that they can also promote mRNA stability. Interestingly, the steady-state level of ARE-containing mRNA can be increased upon treatment of cells with phorbol esters and calcium ionophores (9), a treatment which presumably leads to phosphorylation mediated by protein kinase C. The AUF1/hnRNP-D proteins are phosphoproteins (66) , and such a modification could affect their RNA-binding and/or proteinprotein interaction capacity and result in their association with a different set of proteins that can stabilize ARE-containing mRNAs. It is also possible that additional ARE-binding proteins other than the AUF1/hnRNP-D proteins similarly facilitate stability. Conversely, the possible role of the ␣CPs in ARE-mediated mRNA turnover is not known. However, phosphorylation of the ␣CPs diminishes their RNA-binding activity (40) and might provide a mechanism for releasing them from one RNA substrate and for allowing them to interact with another. 1 to 4) or hnRNP-K (lanes 5 to 8) was incubated with either GST-␣CP1, GST-␣CP2, or GST and interacting proteins were isolated and resolved by SDS-PAGE as described for Fig. 2. (B) 32 P-labeled poly(C) oligonucleotide (oligo) (C 20 ) incubated with the indicated fusion proteins coupled to glutathione beads as for panel A. Bound [
32 P]C 20 was eluted from the proteins and resolved on a 15% polyacrylamide-7 M urea gel, followed by autoradiography. The blot was stripped with 1% SDS and reprobed with the hnRNP-C-specific antibody (4F4). The fainter top band is hnRNP-C1, and the more-intense lower band is hnRNP-C2. Lanes: 1, aliquot of total K562 extract; 2, ␣CPs; 3, negative control of S130 extract alone (without ␣3ЈUTR RNA) comigrating with the ␣-complex.
The presence of the ␣CP and AUF1/hnRNP-D proteins, as well as the entire ␣-complex, in nonerythroid cells (1, 20, 45, 62) indicates that they might be general mRNA stability factors and can influence the fate of nonglobin mRNA as well. Several recent observations further support the role of the ␣CPs as general mRNA turnover regulators. These include (i) the role of AUF1/hnRNP-D in ARE-directed mRNA turnover (4, 14, 66) ; (ii) the demonstration that the ␣-complex forms on three stable mRNAs, ␣(I)-collagen, 15-lipoxygenase, and tyrosine hydrolase (40a); and (iii) the interaction of the murine ␣CP2 with the msy-1 protein (19), a protein which masks paternal mRNA translation in spermatocytes (56) and possibly stabilizes the same mRNAs. Our data demonstrate that the ␣-complex could consist of two ␣CPs, four AUF1/hnRNP-D proteins, and possibly four additional unidentified proteins having apparent molecular masses of 58, 55, 50, and 28 kDa. Whether all of these proteins are simultaneously within the ␣-complex or whether some are mutually exclusive is unknown at present. However, the observation that ␣CP2 interacts weakly with AUF1/hnRNP-D is suggestive that subclasses of ␣-complexes might exist. For example, a particular ␣CP contained within a given ␣-complex could dictate the composition of proteins recruited to that mRNA and in turn regulate the degree of its mRNA stability or instability.
The ␣-complex could regulate the stability of mRNA in both the nuclear and the cytoplasmic compartments. AUF1/ hnRNP-D proteins are predominantly nuclear but are contained in both the cytoplasmic and nuclear compartments (66) and are members of a subclass of RNA-binding proteins that shuttle between the cytoplasm and nucleus (44a) . Similarly, the mouse homolog of ␣CP2 (mCBP) is predominantly nuclear yet also contained in both cellular compartments (19) , as is the epitope-tagged human ␣CP1 (37a). Therefore, the ␣CP and AUF1/hnRNP-D proteins could be present within the ␣-complex in the nucleus and cytoplasm and could mediate mRNA stability in both cellular compartments as well as during nucleocytoplasmic translocation.
The AUF1/hnRNP-D proteins have independently been isolated by three groups and have been postulated to possess different functions. We had initially identified these proteins as an activity which bound the AϩU-rich mRNA instability element and mediated rapid c-myc mRNA turnover in in vitro decay assays (4, 66) . This activity was termed AUF1 (4). Ishikawa et al. (26) identified an activity that bound telomeric sequences in vitro and subsequently demonstrated this activity to consist of the hnRNP D family of pre-mRNA binding proteins (31) . It is possible that the AUF1/hnRNP-D proteins could be involved in stabilization of mRNA as a component of the ␣-complex as well as stabilization of DNA by binding to the ends of chromosomes. Tay et al. (57) have described a protein almost identical to the AUF1/hnRNP-D proteins and possibly derived from the same gene, termed E2BP, which binds to the hepatitis B virus enhancer EII region and augments transcription (57) . It is unclear why the AUF1/hnRNP-D proteins are involved in several different functions, although many RNAbinding proteins have been implicated or directly demonstrated to contain multiple functions unrelated to RNA processing (reference 22; for a review, see reference 24). Two examples of proteins involved in mRNA turnover and which have additional functions are xrn1 and the iron response proteins (IRP). xrn1 is a yeast 5Ј-to-3Ј exoRNase which appears to also function in mitotic recombination, mitotic spindle assembly, nuclear fusion, and replication of minichromosomes (for a review, see reference 33). IRP is an iron-sulfur protein which binds to and stabilizes transferrin mRNA in the low-iron state (3Fe-4S) and possesses aconitase enzyme activity in the highiron state (4Fe-4S) (25, 32, 34, 48) .
In contrast to the wealth of knowledge available concerning protein-protein interaction domains of transcription factors, very little is known about protein-protein interaction domains of RNA-binding proteins. In the case of RNP-CS-containing proteins such as hnRNP A1, the glycine-rich C-terminal domain is believed to mediate protein-protein interactions (11, 46, 52, 63) . The AUF1/hnRNP-D proteins also contain a glycine-rich C terminus which might be the protein-protein interaction domain. Less is known about the protein-protein interaction domain of KH domain-containing proteins such as the ␣CPs. These are an important subclass of RNA-binding proteins which include the protein encoded at the fragile X mental retardation loci, FMR1 (59), its related proteins FXR1 (54) and FXR2 (67), the Src-associated protein Sam68 (15), the paraneoplastic opsoclonus-ataxia-associated Ri antigen nova (6) , and the tumor suppressor protein GLD-1 (30) .
It is intriguing that the highly homologous ␣CPs exhibit a differential degree of interaction with AUF1/hnRNP-D. The two ␣CPs are almost identical throughout their three KH domains (93% identity), which are thought to be the RNA-binding domains in other KH domain-containing proteins (27, 41, 53, 58) . Therefore, the most likely region to house the proteinprotein interaction domain of ␣CP1 is the 140-amino-acid linker region separating the second and third KH domains (amino acids 150 to 290). A 70-amino-acid segment (amino acids 175 to 245) within this region contains divergent sequences and could be the likely candidate for the interaction domain. Mapping of the interaction domain as well as identification of the full complement of ␣CP is currently under way to facilitate understanding of the mechanism by which the ␣-complex influences mRNA turnover.
